Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Matrix Biol. 2013 Aug 31;34:64–79. doi: 10.1016/j.matbio.2013.08.004

Table II.

Bound Active Molecules that can be Released by Perlecan Turnover

Binding Partner Binding
Domain
Affinity Bioactivity References
acetylcholinesterase HS (avian) unreported NMJ function (Peng et al., 1999)
activin A HS unreported tissue growth and repair (Li et al., 2010)
BMP-1 HS 573 pM osteogenesis (Decarlo et al., 2012)
BMP-2 HS 600 pM osteogenesis/
chondrogenesis
(Decarlo et al., 2012)
FGF-1 HS unreported tissue growth and repair (Melrose et al., 2006)
FGF-2 HS 0.6–2 nM; 12 nM tissue growth and repair (Chu et al., 2005; Knox et al., 2002)
FGF-9 HS unreported tissue growth and repair (Melrose et al., 2006)
HB-EGF HS 44 nM; 6.1 nM tissue growth and repair (Chu et al., 2005)
histone H1 HS unreported tissue growth and repair (Henriquez et al., 2002)
IL-2 (mouse) HS unreported inflammation; immune
surveillance
(Miller et al., 2008)
LTBP-2 HS unreported release of TGFβ (Parsi et al., 2010)
Thrombospondin-1 HS unreported tissue remodeling and
repair
(Vischer et al., 1997)
VEGF165 HS “high” tissue growth
/angiogenesis
(Zoeller et al., 2009)
WNTsa/Wg HS 0.01–0.1 nM tissue development and
growth
(Lin, 2004; Reichsman et al., 1996)
Hedgehogs (Hhs)a HS/Core
Protein
“high” tissue development and
growth
(Datta et al.,
2006; Lin, 2004; Park et al., 2003)
TGF beta HS/Core
Protein
low nM tissue growth and repair (Cheifetz and Massague, 1989; Harrison et al., 2011)
LDL & VLDL II “high” cholesterol and lipid
delivery
(Hummel et al., 2004)
FGF-7 III 60 nM tissue growth and repair (Mongiat et al., 2000)
FGF-18 III 27.8 nM tissue growth/chondrogenesis (Smith et al., 2007)
FGF-bp III - second
laminin-EGF
repeat
18 nM release of FGF (Mongiat et al., 2001)
PDGF III - second
laminin-EGF
repeat
8–25 nM tissue growth
/angiogenesis
(Gohring et al., 1998)
FGF-7 V 60 nM tissue growth and repair (Mongiat et al., 2000)
myostatin (mouse) V (mouse) 11 nM regulation of muscle mass (Sengle et al., 2011)
Progranulin V 1 µM blood vessel growth (Gonzalez et al., 2003)
VEGFR1 V 10.6 nM VEGF signaling;
angiogenesis
(Goyal et al., 2011)
VEGFR2 V 2.8 nM VEGF signaling;
angiogenesis
(Goyal et al., 2011)
a

Extrapolated from genetic and diffusion data.